116-1
Mus musculus
Protocols: Mice were exposed to 45 min ischemia followed by 3 days reperfusion. During reperfusion mice were treated with IGF1 (bolus of 40 ng/g followed by 1 µg/g/d via osmotic minipumps) or vehicle (0.1%BSA). In each sample 1 control and 1 IGF1 treated mouse are combined. Hashtag labels indicate previous treatment (TotalSeq B0301 (Biolegend 155831) - control, TotalSeq B0302 (Biolegend 155833) - IGF1) After 3 days hearts were digested in a collagenase solution and CD45+Cd11b+ cells were isolated from the heart by FACS sorting. Chromium Next GEM Single Cell 3ʹReagent Kits v3.1 Chromium Next GEM Single Cell 3ʹReagent Kits v3.1
ENA-FIRST-PUBLIC
2023-12-31T01:12:41Z
ENA-LAST-UPDATE
2023-12-31T01:12:41Z
External Id
SAMEA13857306
INSDC center name
Heinrich-Heine-Universitat Dusseldorf Biologisch-Medizinisches Forschungszentrum (BMFZ) Genomics & Transcriptomics Labor (GTL) West-German Genome Center (WGGC)
INSDC first public
2023-12-31T01:12:41Z
INSDC last update
2023-12-31T01:12:41Z
INSDC status
public
Submitter Id
E-MTAB-11590:116-1
broker name
ArrayExpress
cell_type
myeloid cell
common name
house mouse
disease
myocardial infarction
immunophenotype
CD45+ Cd11b+
isolate
not applicable
organism part
heart
sample name
E-MTAB-11590:116-1
scientific_name
Mus musculus
stimulus
control/IGF1 (see additional file)
strain
C57BL/6J